Evidence map›Paper›PMID 19942296›Full record

ArticleJournal of reproductive immunology2010

Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.

Alison J Johnson, Michelle H Nelson, Melanie D Bird, Chin-Fun Chu, Gregg N Milligan

Abstract read
In one paragraph

Article in Journal of reproductive immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Herpes Simplex Virus Evasion of Early Host Antiviral Responses.Frontiers in cellular and infection microbiology · 2019
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alison J JohnsonDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Michelle H Nelson
Melanie D Bird
Chin-Fun Chu
Gregg N Milligan
The University of Texas Medical Branch at Galveston · US

Funding

PROTECTION OF GENITAL MUCOSA AND GANGLIA AGAINST HSV-2R01AI042815 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MILLIGAN, GREGG N. · 1999 to 2010
$2.1M
Vaccine-elicited genital and neuronal T cell responsesR01AI054555 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MILLIGAN, GREGG N. · 2003 to 2007
$1.8M
NIAID NIH HHS AI05444NIAID NIH HHS AI42815NIAID NIH HHS R01 AI042815NIAID NIH HHS R01 AI054555
6 · The paper itself

Abstract

Interferon gamma (IFNgamma) is important for immune resistance to herpes simplex virus (HSV) infection. To examine the influence of IFNgamma on the development of HSV-specific immune responses and test for IFNgamma-independent adaptive immune mechanisms of protection, IFNgamma-deficient mice (IFNgamma(-/-)) were immunized with thymidine kinase-deficient HSV-2 (HSV-2 333tk(-)). HSV-specific cellular and humoral responses were elicited in immunized IFNgamma(-/-) mice resulting in increased resistance relative to non-immune C57BL/6J (B6) mice following challenge with fully virulent HSV-2. CD8(+) T cells from IFNgamma(-/-) mice displayed cytotoxic activity and secreted TNFalpha. HSV-specific CD4(+) T cells from immunized IFNgamma(-/-) mice secreted IL-4, TNFalpha, and IL-17, but unlike T cells from HSV-immune B6 mice, could not clear virus from genital tissue following adoptive transfer. HSV-immune IFNgamma(-/-) mice produced predominantly IgG(1) HSV-specific antibodies while immune B6 mice produced predominantly IgG(2c) antibodies. Transfer of equivalent amounts of HSV-specific antibodies from either strain to naïve mice imparted equivalent early resistance against infection of the genital epithelia. However, protection against neurological symptoms mediated by immune B6 antibodies was superior late in infection. Taken together, these results demonstrate that the limited resistance of HSV-immune IFNgamma(-/-) mice to HSV-2 infection resulted from the action of HSV-specific Ab rather than IFNgamma-independent effector functions of T cells. Further, protection against neurological manifestations of HSV-2 infection was superior in mice receiving Ab from immune B6 mice suggesting that Ab-mediated protective mechanisms involving IFNgamma-induced IgG subclasses were more effective once virus had spread to neural tissues.

Indexed as

Adoptive TransferAnimalsAntibodies, ViralCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHerpes GenitalisHerpes SimplexHerpesvirus 2, HumanInterferon-gammaInterleukin-17Interleukin-4Lymphocyte ActivationMiceMice, Inbred C57BLMice, Mutant StrainsAntibodies, ViralInterferon-gammaInterleukin-17Interleukin-4Thymidine KinaseTumor Necrosis Factor-alpha

Identifiers

PMID19942296
PMCPMC2815080
OpenAlexW2022039811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.